Stay updated on Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial

Sign up to get notified when there's something new on the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now presents the completed Phase 2 AML study record, including its treatment approach, participant criteria, outcomes, investigators, results-related publications, and study documents, instead of an access error.
    Difference
    48%
    Check dated 2026-11-08T13:56:05.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.2 to v3.8.0; the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:26:18.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T14:32:03.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 on the error page.
    Difference
    0.2%
    Check dated 2026-10-18T14:47:00.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer’s displayed ClinicalTrials.gov revision changes from v3.7.0 to v3.7.1 on a 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-11T15:23:50.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, replacing the previous detailed study content with a minimal error page that includes a Home link and a revision notice.
    Difference
    18%
    Check dated 2026-09-20T19:29:25.000Z thumbnail image

Stay in the know with updates to Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page.